SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-000861
Filing Date
2020-01-03
Accepted
2020-01-03 06:06:06
Documents
5
Period of Report
2019-12-31
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 1.02: Termination of a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d860822d8k.htm 8-K 20701
2 EX-10.1 d860822dex101.htm EX-10.1 647305
3 GRAPHIC g860822page71a.jpg GRAPHIC 1034
4 GRAPHIC g860822page71b.jpg GRAPHIC 929
5 GRAPHIC g860822page71c.jpg GRAPHIC 926
  Complete submission text file 0001193125-20-000861.txt   673728
Mailing Address 18 CROSBY DRIVE BEDFORD MA 01730
Business Address 18 CROSBY DRIVE BEDFORD MA 01730 617-674-9000
Kaleido Biosciences, Inc. (Filer) CIK: 0001751299 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38822 | Film No.: 20503302
SIC: 2836 Biological Products, (No Diagnostic Substances)